Anticancer effects of vecuronium bromide and cisatracurium besylate on lung cancer cells (A549), in vitro - 22/10/14
Abstract |
Neuromuscular blocking drugs are used in anesthesia and intensive care to provide skeletal muscle relaxation. However, literature has revealed that the effects of these drugs on cancer have not been widely studied. We tested the effects of two non-depolarising neuromuscular blocking drugs, vecuronium bromide and cisatracurium besylate on lung cancer cells’ (A549) proliferation, migration and viability in the presence of a cytotoxic drug, cisplatin. We demonstrated in this study that both neuromuscular blocking agents inhibit lung cancer cells’ proliferation. In addition, the study revealed that vecuronium bromide and cisatracurium besylate was synergistic to cisplatin in reducing lung cancer cell proliferation. However, vecuronium inhibits lung cancer cells migration in vitro.
El texto completo de este artículo está disponible en PDF.Keywords : Vecuronium bromide, Cisatracurium besylate, Cisplatin, Lung cancer, A549 cells
Esquema
Vol 4 - N° 4
P. 349-353 - octobre 2014 Regresar al número
Artículo precedente
- Screening for the modulation of neovessel formation in non-tumorigenic and tumorigenic conditions using three different plants native to Western ghats of India
- B.R. Vijay Avin, Prabhu Thirusangu, C.K. Ramesh, V. Vigneshwaran, M.V. Prashanth Kumar, Riaz Mahmood, B.T. Prabhakar
- Matricaria Chamomilla extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine
- Zahra Alibabaei, Zahra Rabiei, Samira Rahnama, Shiva Mokhtari, Mahmoud Rafieian-kopaei
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?